|
Market Closed -
Nasdaq
16:30:00 2026-11-20 EST
|
5-day change | 1st Jan Change | ||
| 0.5400 USD | -12.97% |
|
-16.16% | -69.66% |
| 11-20 | InspireMD, Inc. - Special Call | |
| 11-18 | InspireMD Inc Announces First U.S. Commercial TCAR Procedures Using FDA-Approved CGuard Prime TransCarotid Stent System | CI |
| Market Cap | 29.23M 26.62M 24.53M 22.31M 41.86M 2.71B 44M 299M 119M 1.48B 110M 107M 4.64B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 29.23M 26.62M 24.53M 22.31M 41.86M 2.71B 44M 299M 119M 1.48B 110M 107M 4.64B | EV / Sales 2026 * |
2.98x | EV / Sales 2027 * | 1.78x |
| Free-Float |
69.28% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NSPR | Delayed | |
| NSPR | Real-time | ||
| II2 | Delayed | ||
| II2 | Delayed | ||
| II2 | Real-time | ||
| II2 | Real-time |
Last Transcript: InspireMD, Inc.
| 1 day | -12.97% | ||
| 1 week | -16.16% | ||
| Current month | +20.00% | ||
| 1 month | +20.51% | ||
| 3 months | -39.99% | ||
| 6 months | -47.57% | ||
| Current year | -69.66% |
| 1 week | 0.5 | 0.69 | |
| 1 month | 0.43 | 0.82 | |
| Current year | 0.43 | 1.98 | |
| 1 year | 0.43 | 2.17 | |
| 3 years | 0.43 | 3.8 | |
| 5 years | 0.43 | 3.85 | |
| 10 years | 0.43 | 104,734.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 62 | 2019-12-31 |
Michael Lawless
DFI | Director of Finance/CFO | 58 | 2025-06-24 |
Shany Barel
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Stuka
CHM | Chairman | 71 | 2017-06-01 |
Michael Berman
BRD | Director/Board Member | 68 | 2013-02-06 |
Marvin Slosman
BRD | Director/Board Member | 62 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/18/26 | Others | Director | -183,746 | 0.3952% | ||
| 9/18/26 | Osiris Investment Partners LLC
| Others | Company | -262,500 | 0.5646% | |
| 9/18/26 | Others | Director | -91,874 | 0.1976% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -12.97% | -16.16% | -72.02% | -78.82% | 29.23M | ||
| -0.84% | -5.09% | -19.60% | +1.07% | 178B | ||
| -0.67% | -2.84% | -1.25% | +27.12% | 122B | ||
| -0.98% | +0.12% | -15.82% | +5.56% | 118B | ||
| -1.24% | -4.25% | -42.94% | -1.34% | 88.1B | ||
| -0.63% | -5.55% | -7.27% | +70.54% | 64.71B | ||
| +0.05% | -2.41% | +10.41% | -9.90% | 57.96B | ||
| -1.95% | -3.98% | -6.85% | +41.55% | 53.28B | ||
| -2.91% | -4.35% | -0.97% | +38.45% | 47.8B | ||
| -1.64% | +1.50% | +1.30% | -2.04% | 35.65B | ||
| Average | -2.38% | -3.98% | -15.50% | +9.22% | 77B | |
| Weighted average by Cap. | -1.04% | -2.97% | -12.44% | +15.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.82M 8.94M 8.24M 7.5M 14.07M 909M 14.78M 100M 39.87M 497M 36.85M 36.07M 1.56B | 16.41M 14.95M 13.77M 12.53M 23.5M 1.52B 24.7M 168M 66.62M 830M 61.57M 60.27M 2.6B |
| Net income | - | - |
| Net Debt | - | - |
Employees
127
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-20 | US$0.5400 | -12.97% | 634,003 |
| 26-11-19 | US$0.6205 | -9.50% | 400,194 |
| 26-11-18 | US$0.6856 | +5.48% | 501,936 |
| 26-11-17 | US$0.6500 | +8.33% | 496,426 |
| 26-11-16 | US$0.6000 | -6.85% | 322,491 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.5400USD
Average target price
2.667USD
Spread / Average Target
+393.83%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NSPR Stock
Select your edition
All financial news and data tailored to specific country editions
















